Ipsen S.A. publishes its 2024 consolidated financial statements
Ipsen S.A. publishes its 2024 consolidated financial statements
Ipsen S.A. – 2024 Consolidated Financial Statements
Attachment

Ipsen S.A. publishes its 2024 consolidated financial statements
Ipsen S.A. – 2024 Consolidated Financial Statements
Attachment

Related stories
Tester l’hypothèse : un pilote ciblé sur l’IA dans le domaine de la santé
Toujours une longueur d’avance : Anne Petit et l’art de concrétiser les médicaments
Des données aux décisions : comment Ipsen transforme les données médicales en actions pour les patients
Related Press Releases
IPSEN – Buy-back programme – Art 5 of MAR –...
Ipsen – June 2026 – Monthly information relative to the...
Ipsen – Half year statement – 2026 06 30
IPSEN – Buy-back programme – Art 5 of MAR –...
IPSEN – Buy-back programme – Art 5 of MAR –...
Ipsen to acquire Memo Therapeutics AG, adding first-in-class BK polyomavirus...
Ipsen to acquire Kartos Therapeutics, expanding hemato-oncology late-stage pipeline
IPSEN – Buy-back programme – Art 5 of MAR –...
IPSEN – Buy-back programme – Art 5 of MAR –...
Ipsen – May 2026 – Monthly information relative to the...